Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8303 USD | -2.33% | -7.74% | -38.50% |
15/05 | INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
18/04 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-38.50% | 31.83L | |
-6.03% | 18TCr | |
+1.08% | 11TCr | |
-2.19% | 6.89TCr | |
-5.98% | 4.64TCr | |
+12.31% | 4.54TCr | |
+7.38% | 4.33TCr | |
+15.98% | 3TCr | |
+16.10% | 2.52TCr | |
-6.79% | 2.33TCr |
- Stock Market
- Equities
- INVO Stock
- News INVO Bioscience, Inc.
- INVO Biosciences Announces the Appointment of Jeffrey J. Segal as a Director of the Company